Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WuXi Biologics
Biotech
BioNTech pays WuXi $20M for 2 preclinical monoclonal antibodies
WuXi Biologics accepted a $20 million offer for preclinical monoclonal antibodies against two undisclosed targets.
Nick Paul Taylor
Jan 11, 2024 9:23am
WuXi CRDMO spinoff WuXi XDC partners with IntoCell
Jan 3, 2024 11:05am
Mediar gets a spark from Pfizer's Ignite program
Oct 25, 2023 10:50am
GSK pays WuXi $40M for preclinical anti-cancer bispecific
Jan 5, 2023 5:45am
CANbridge posts early-phase data on rival to AstraZeneca drug
Feb 7, 2022 8:35am
WuXi taps vet Dong to helm new vaccines unit—Chutes & Ladders
Aug 14, 2020 7:56am
